BioSpace News Archive

Urology Devices Market is projected to reach US$ 58.3 Bn by 2026

The global urology devices market is driven by high prevalence and rapid increase in incidence of urology disorder associated with the urinary tract system across the globe.

October 7, 2020
·
6 min read
Portable Oxygen Concentrators Market: Covid-19 Impact On Global Market Demand, Opportunities, And Analysis & Forecast to 2026

The global portable oxygen concentrators market is expected to reach a value of about US$ 2,482.0 Mn by the end of 2026, expanding at a high single digit CAGR during the forecast period.

October 7, 2020
·
6 min read
PARP Inhibitors Market: Focus on Targeted Therapies for Ovarian Cancer Boosting PARP Inhibitors Market

Poly polymerase is implicated in intracellular DNA repair pathways. PARP1/PARP2 have been extensively studied.

October 7, 2020
·
3 min read
Mobility Aid Devices Market: Advancements in Technologies such as Self Driving Wheelchairs and Pneumatic Waterproof Powered Wheelchair to Boost Market

The global mobility aid devices market is on an upward growth curve and as per Transparency Market Research, it will record a steady growth rate, compounded annually, over the forecast period of 2018 to 2026.

October 7, 2020
·
7 min read
Mobile Heart Monitoring Market: Activity monitors segment is expected to account for a high share of the market

Nowadays, the Internet of Things is widely recognized by analysts and researchers as the most sophisticated technology, which has potential to not only affect the safety, health, and productivity of many people but also has a big economic impact.

October 7, 2020
·
5 min read
Laser Aesthetic Devices Market: Body contouring devices holds the larger market share

Laser aesthetics utilize medical devices that assist in the treatment of skin and body defects using minimal or non-invasive techniques.

October 7, 2020
·
5 min read
Drug Development

Pluristem Expands its Phase II COVID-19 European Clinical Trial to Israel

Pluristem Therapeutics Inc. announced that it has received approval from the Israeli Ministry of Health to commence patient enrollment in Israel for the Company’s COVID-19 Phase II clinical trial, under the protocol that was approved by the Paul Ehrlich Institute, Germany’s regulatory agency.

October 7, 2020
·
6 min read
Business

Polyneuron Appoints Aled Williams as Chief Business Officer

Polyneuron Pharmaceuticals AG, a clinical stage developer of a new class of antigen-specific polymers for the treatment of patients with serious autoimmune diseases, announced the appointment of Aled Williams as Chief Business Officer.

October 7, 2020
·
3 min read
Business

Invitation - Presentation of Sobi’s Q3 2020 results

On 22 October, at 08:00 CET, Swedish Orphan Biovitrum AB will publish its report for the third quarter 2020.

October 7, 2020
·
1 min read
Deals

Forbion Portfolio Company, Enterprise Therapeutics’ First-in-Class TMEM16A Potentiator Program for Treatment of Cystic Fibrosis and Other Respiratory Diseases Acquired by Roche

Forbion, a leading European life sciences venture capital firm, announces that its portfolio company, Enterprise Therapeutics Ltd ’s novel TMEM16A potentiator portfolio has been fully acquired by Roche and will be developed by Genentech, a member of the Roche Group.

October 7, 2020
·
5 min read